An outreach lab partnership helps a major academic health system thrive

A multi-faceted relationship between a major academic health system and Labcorp has delivered significant operational, financial and clinical benefits for the system. In addition to creating a core lab and providing single-source responsibility for a wide range of laboratory testing, Labcorp supports academic research and facilitates access to clinical trials. The achievement of substantial savings has cemented the partnership between the two organizations.

Labcorp establishes comprehensive laboratory relationship with Ascension

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 3, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the completion of transactions that establish a long-term laboratory relationship with Ascension, one of the leading non-profit and Catholic health systems in the United States.

Labcorp Drug Development selects Dr. Deepa Desai as country head for India

BURLINGTON, N.C., Oct. 3, 2022 — Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointment of Dr. Deepa Desai as senior vice president and country head of Labcorp Drug Development India.